Flanagan W. Michael

Insider profile

Flanagan W. Michael's trades of Avidity Biosciences Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
46.40
Quantity 20,000
Value US$928,000
Transaction date
Proposed sale
Price
33.62
Quantity 20,000
Value US$672,400
Transaction date
Proposed sale
Price
30.04
Quantity 20,000
Value US$600,800
Transaction date
Proposed sale
Price
36.10
Quantity 24,000
Value US$866,400
Transaction date
Proposed sale
Price
45.93
Quantity 38,018
Value US$1,746,167
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-01-23 2026-01-21 PlS Planned sale
71,680 -20.5%
285.32
US$1,963,401
71,680 -20.5% 285.32 US$1,963,401
2026-01-23 2026-01-21 PlS Planned sale
52,040 -47.6%
234.73
US$1,110,442
52,040 -47.6% 234.73 US$1,110,442
2026-01-09 2026-01-07 PlS Planned sale
86,819 +33.2%
492.79
US$2,187,860
86,819 +33.2% 492.79 US$2,187,860
2025-09-12 2025-09-11 PlS Planned sale
20,000 -20.0%
38.94
US$778,702
20,000 -20.0% 38.94 US$778,702
2025-09-11 2025-09-11 PrS Proposed sale
20,000
46.40
US$928,000
20,000 46.40 US$928,000
2025-06-12 2025-06-11 PlS Planned sale
20,000 -20.0%
32.88
US$657,694
20,000 -20.0% 32.88 US$657,694
2025-06-11 2025-06-11 PrS Proposed sale
20,000
33.62
US$672,400
20,000 33.62 US$672,400
2025-03-21 2025-03-20 PlS Planned sale
11,780 -12.8%
31.06
US$365,868
11,780 -12.8% 31.06 US$365,868
2025-03-12 2025-03-11 PlS Planned sale
20,000 -17.9%
30.13
US$602,614
20,000 -17.9% 30.13 US$602,614
2025-03-11 2025-03-11 PrS Proposed sale
20,000
30.04
US$600,800
20,000 30.04 US$600,800
2025-01-23 2025-01-21 PlS Planned sale
1,812 -1.9%
28.59
US$51,809
1,812 -1.9% 28.59 US$51,809
2025-01-23 2025-01-21 PlS Planned sale
3,860 -4.0%
28.60
US$110,383
3,860 -4.0% 28.60 US$110,383
2024-12-19 2024-12-18 PlS Planned sale
12,742 -14.9%
32.66
US$416,154
12,742 -14.9% 32.66 US$416,154
2024-12-13 2024-12-11 PlS Planned sale
24,000 -21.9%
35.77
US$858,401
24,000 -21.9% 35.77 US$858,401
2024-12-11 2024-12-11 PrS Proposed sale
24,000
36.10
US$866,400
24,000 36.10 US$866,400
2024-10-03 2024-10-01 PlS Planned sale
62,500 -42.3%
47.62
US$2,976,112
62,500 -42.3% 47.62 US$2,976,112
2024-10-01 2024-10-01 PrS Proposed sale
38,018
45.93
US$1,746,167
38,018 45.93 US$1,746,167
2024-09-23 2024-09-23 PrS Proposed sale
36,329
44.48
US$1,615,914
36,329 44.48 US$1,615,914
2024-09-23 2024-09-23 PlS Planned sale
11,847 -12.2%
43.89
US$519,996
11,847 -12.2% 43.89 US$519,996
2024-09-23 2024-09-23 PlS Planned sale
13,153 -15.3%
44.00
US$578,737
13,153 -15.3% 44.00 US$578,737
2024-09-13 2024-09-11 PlS Planned sale
14,894 -19.7%
40.40
US$601,676
14,894 -19.7% 40.40 US$601,676
2024-09-13 2024-09-11 PlS Planned sale
34,000 -31.0%
40.40
US$1,373,556
34,000 -31.0% 40.40 US$1,373,556
2024-09-13 2024-09-11 PlS Planned sale
62,500 -45.2%
40.40
US$2,525,012
62,500 -45.2% 40.40 US$2,525,012
2024-09-11 2024-09-11 PrS Proposed sale
111,394
40.79
US$4,543,761
111,394 40.79 US$4,543,761
2024-06-20 2024-06-18 PlS Planned sale
10,106 -16.6%
39.13
US$395,445
10,106 -16.6% 39.13 US$395,445
2024-01-23 2024-01-22 PlS Planned sale
4,129 -10.3%
10.13
US$41,827
4,129 -10.3% 10.13 US$41,827